March 06, 2015 1:50 AM ET

Pharmaceuticals

Company Overview of Neurotune AG

Company Overview

Neurotune AG develops medications and diagnostics for unmet medical needs in neuromuscular and renal indications. The company provides medications to treat disorders of the human nervous system and develops treatments, which modulate (tune) the connections between nerve cells and their target cells. It offers CAF ELISA, a diagnostic assay for the detection of the CAF biomarkers; and sandwich ELISA research assays to measure CAF22 (NTCAF ELISA) and totalCAF fragments (CAF110+CAF22, NTtotalCAF ELISA). The company also provides agrin biologic for the treatment of neuromuscular diseases (such as amyotrophic lateral sclerosis, spinal muscle atrophy, MG, CMS), sarcopenia, and (traumatic) nerve inj...

Wagistrasse 27 a

Schlieren,  8952

Switzerland

Founded in 2005

Phone:

41 44 200 21 95

Fax:

41 44 200 20 80

Key Executives for Neurotune AG

Chief Executive Officer and Chief Financial Officer
Chairman of the Board and Head of BD & L
Head of R&D
Chief Scientific Officer
Age: 54
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
F. Hoffmann-La Roche Ltd Europe
Mepha Holding AG Europe
Lurgi TPS AG Europe
Teva Pharma AG Europe
Ixodes AG Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Neurotune AG, please visit www.neurotune.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.